1.    Weintraub D, Comella CL, Horn S. Parkinson's disease-Part 1: Pathophysiology, symptoms, burden, diagnosis,        and assessment. Am J Manag Care 2008; 14 (2 Suppl): S40–48.
2.    Poewe W, Mahlknecht P. The clinical progression of Parkinson's disease. Parkinsonism Relat Disord 2009; 15 (Suppl 4):
       S28–S32.
3.    Chaudhuri KR, Ondo W. Handbook of Movement Disorders. London: Current Medicine Group, 2009.
4.    Goldman JG, Postuma R. Premotor and nonmotor features of Parkinson’s disease. Curr Opin Neurol 2014; 27 (4): 434–441.
5.    Kalia LV, Lang AE. Parkinson’s disease. Lancet 2015; 386 (9996): 896–912.
6.    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence,        and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis        for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159): 1789–1858.
7.    Kowal SL, Dall TM, Chakrabarti R, et al. The current and projected economic burden of Parkinson’s disease in the United            States. Mov Disord 2013; 28 (3): 311–318.
8.   de Lau LML, Breteler Monique MB. Epidemiology of Parkinson's disease. Lancet Neurol 2006; 5 (6): 525–535.
9.   Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous   
      nations, 2005 through 2030. Neurology 2007; 68 (5): 384–386.
10.  Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 79 (4): 368–376.
11.  Williams DR, Litvan I. Parkinsonian syndromes. Continuum (Minneap Minn) 2013; 19 (5): 1189–1212.

1. World Health Organization. Neurological Disorders: Public Health Challenges. 2006. (http://www.who.int/mental_health/publications/neurological_disorders_ph_challenges/en/)
2. Schapira AHV The management of Parkinson’s disease - what is new? Eur J Neurol 2011;18(Suppl 1):12.
3. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis  for the Global Burden of Disease Study 2017. Lancet 2018; 392 (10159): 1789–1858
   
4. Weintraub D, Comella CL, Horn S. Parkinson's disease-Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment. Am J Manag Care. 2008; 14(2 Suppl):S40-8.
5. Kowal SL, Dall TM, Chakrabarti R, et al. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord 2013; 28 (3): 311–318.
6. Tysnes & Storstein. Epidemiology of Parkinson's disease. J Neural Transm 2017;124:901-905.